BioLife Solutions, Inc. Revenue from Contract with Customer, Including Assessed Tax
BioLife Solutions, Inc. (BLFS) reported Revenue from Contract with Customer, Including Assessed Tax of $28.47 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement
us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax · last filed 2026-08-06
- BioLife Solutions, Inc. revenue from contract with customer, including assessed tax for the quarter ending 2026-06-30 was $28.47M, a 21.45% increase year-over-year.
- BioLife Solutions, Inc. revenue from contract with customer, including assessed tax for the quarter ending 2026-03-31 was $27.50M, a 24.69% increase year-over-year.
- BioLife Solutions, Inc. revenue from contract with customer, including assessed tax for the quarter ending 2025-12-31 was $18.79M, a 24.34% increase year-over-year.
- BioLife Solutions, Inc. revenue from contract with customer, including assessed tax for the quarter ending 2025-09-30 was $28.07M, a 31.21% increase year-over-year.
- BioLife Solutions, Inc. revenue from contract with customer, including assessed tax for fiscal 2025 was $96.21M, a 28.89% increase from fiscal 2024.
- BioLife Solutions, Inc. revenue from contract with customer, including assessed tax for fiscal 2024 was $74.65M, a 9.75% increase from fiscal 2023.
- BioLife Solutions, Inc. revenue from contract with customer, including assessed tax for fiscal 2023 was $68.02M, a 10.79% decline from fiscal 2022.
- BioLife Solutions, Inc. revenue from contract with customer, including assessed tax for fiscal 2022 was $76.24M, a 36.02% decline from fiscal 2021.
| Period end | Revenue from Contract with Customer, Including Assessed Tax 3 month | Revenue from Contract with Customer, Including Assessed Tax 3 month as first filed | Revenue from Contract with Customer, Including Assessed Tax 6 month | Revenue from Contract with Customer, Including Assessed Tax 6 month as first filed | Revenue from Contract with Customer, Including Assessed Tax 9 month | Revenue from Contract with Customer, Including Assessed Tax 9 month as first filed | Revenue from Contract with Customer, Including Assessed Tax 12 month | Revenue from Contract with Customer, Including Assessed Tax 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $28.47M 10-Q · filed 2026-08-06 | $55.97M 10-Q · filed 2026-08-06 | $74.75M derived: sum of 3 quarters · filed 2026-08-06 | $102.82M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | $27.50M 10-Q · filed 2026-05-07 | $46.28M derived: sum of 2 quarters · filed 2026-05-07 | $74.35M derived: sum of 3 quarters · filed 2026-05-07 | $97.79M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | $18.79M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $46.85M derived: sum of 2 quarters · filed 2026-02-26 | $70.29M derived: sum of 3 quarters · filed 2026-08-06 | $96.21M 10-K · filed 2026-02-26 | ||||
| 2025-09-30 | $28.07M 10-Q · filed 2025-11-06 | $51.51M derived: sum of 2 quarters · filed 2026-08-06 | $77.43M 10-Q · filed 2025-11-06 | $88.67M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | $23.44M 10-Q · filed 2026-08-06 | $25.42M 10-Q · filed 2025-08-07 | $45.49M 10-Q · filed 2026-08-06 | $49.36M 10-Q · filed 2025-08-07 | $60.60M derived: sum of 3 quarters · filed 2026-08-06 | $81.99M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-03-31 | $22.05M 10-Q · filed 2026-05-07 | $23.94M 10-Q · filed 2025-05-08 | $37.16M derived: sum of 2 quarters · filed 2026-05-07 | $58.55M derived: sum of 3 quarters · filed 2026-05-07 | $78.27M derived: sum of 4 quarters · filed 2026-05-07 | |||
| 2024-12-31 | $15.11M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $36.50M derived: sum of 2 quarters · filed 2026-02-26 | $56.21M derived: sum of 3 quarters · filed 2026-02-26 | $74.65M 10-K · filed 2026-02-26 | $82.25M 10-K · filed 2025-03-03 | |||
| 2024-09-30 | $21.39M 10-Q · filed 2025-11-06 | $30.57M 10-Q · filed 2024-11-12 | $41.11M derived: sum of 2 quarters · filed 2025-11-06 | $59.54M 10-Q · filed 2025-11-06 | $85.68M 10-Q · filed 2024-11-12 | $45.56M derived: sum of 4 quarters · filed 2026-02-26 | ||
| 2024-06-30 | $19.71M 10-Q · filed 2025-08-07 | $28.33M 10-Q · filed 2024-08-09 | $38.15M 10-Q · filed 2025-08-07 | $55.11M 10-Q · filed 2024-08-09 | $24.17M derived: sum of 3 quarters · filed 2026-02-26 | $47.74M derived: sum of 4 quarters · filed 2026-02-26 | ||
| 2024-03-31 | $18.43M 10-Q · filed 2025-05-08 | $31.73M 10-Q · filed 2024-05-10 | $4.46M derived: sum of 2 quarters · filed 2026-02-26 | $28.03M derived: sum of 3 quarters · filed 2026-02-26 | $57.27M derived: sum of 4 quarters · filed 2026-02-26 | |||
| 2023-12-31 | -$13.98M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $9.60M derived: sum of 2 quarters · filed 2026-02-26 | $38.83M derived: sum of 3 quarters · filed 2026-02-26 | $68.02M 10-K · filed 2026-02-26 | $143.27M 10-K · filed 2024-02-29 | |||
| 2023-09-30 | $23.57M 10-Q · filed 2024-11-12 | $33.33M 10-Q · filed 2023-11-09 | $52.81M derived: sum of 2 quarters · filed 2024-11-12 | $81.99M 10-Q · filed 2024-11-12 | $110.54M 10-Q · filed 2023-11-09 | $49.25M derived: sum of 4 quarters · filed 2025-03-03 | ||
| 2023-06-30 | $29.24M 10-Q · filed 2024-08-09 | $39.51M 10-Q · filed 2023-08-09 | $58.42M 10-Q · filed 2024-08-09 | $77.21M 10-Q · filed 2023-08-09 | $25.68M derived: sum of 3 quarters · filed 2025-03-03 | $66.43M derived: sum of 4 quarters · filed 2025-03-03 | ||
| 2023-03-31 | $37.70M 10-Q · filed 2024-05-10 | -$3.56M derived: sum of 2 quarters · filed 2025-03-03 | $37.19M derived: sum of 3 quarters · filed 2025-03-03 | $77.72M derived: sum of 4 quarters · filed 2025-03-03 | ||||
| 2022-12-31 | -$41.26M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | -$514.00K derived: sum of 2 quarters · filed 2025-03-03 | $40.02M derived: sum of 3 quarters · filed 2025-03-03 | $76.24M 10-K · filed 2025-03-03 | $161.76M 10-K · filed 2023-03-31 | |||
| 2022-09-30 | $40.75M 10-Q · filed 2023-11-09 | $81.28M derived: sum of 2 quarters · filed 2023-11-09 | $117.50M 10-Q · filed 2023-11-09 | $154.81M derived: sum of 4 quarters · filed 2024-02-29 | ||||
| 2022-06-30 | $40.53M 10-Q · filed 2023-08-09 | $76.75M 10-Q · filed 2023-08-09 | $114.06M derived: sum of 3 quarters · filed 2024-02-29 | $147.86M derived: sum of 4 quarters · filed 2024-02-29 | ||||
| 2022-03-31 | $36.22M 10-Q · filed 2023-05-11 | $73.53M derived: sum of 2 quarters · filed 2024-02-29 | $107.33M derived: sum of 3 quarters · filed 2024-02-29 | $138.53M derived: sum of 4 quarters · filed 2024-02-29 | ||||
| 2021-12-31 | $37.30M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $71.11M derived: sum of 2 quarters · filed 2024-02-29 | $102.31M derived: sum of 3 quarters · filed 2024-02-29 | $119.16M 10-K · filed 2024-02-29 | ||||
| 2021-09-30 | $33.80M 10-Q · filed 2022-11-09 | $65.00M derived: sum of 2 quarters · filed 2022-11-09 | $81.85M 10-Q · filed 2022-11-09 | $96.58M derived: sum of 4 quarters · filed 2023-03-31 | ||||
| 2021-06-30 | $31.20M 10-Q · filed 2022-08-09 | $48.05M 10-Q · filed 2022-08-09 | $62.78M derived: sum of 3 quarters · filed 2023-03-31 | $74.06M derived: sum of 4 quarters · filed 2023-03-31 | ||||
| 2021-03-31 | $16.85M 10-Q · filed 2022-05-10 | $31.57M derived: sum of 2 quarters · filed 2023-03-31 | $42.85M derived: sum of 3 quarters · filed 2023-03-31 | $52.77M derived: sum of 4 quarters · filed 2023-03-31 | ||||
| 2020-12-31 | $14.73M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $26.00M derived: sum of 2 quarters · filed 2023-03-31 | $35.92M derived: sum of 3 quarters · filed 2023-03-31 | $48.09M 10-K · filed 2023-03-31 | ||||
| 2020-09-30 | $11.28M 10-Q · filed 2021-11-15 | $21.20M derived: sum of 2 quarters · filed 2021-11-15 | $33.36M 10-Q · filed 2021-11-15 | $41.66M derived: sum of 4 quarters · filed 2022-03-31 | ||||
| 2020-06-30 | $9.92M 10-Q · filed 2021-08-16 | $22.08M 10-Q · filed 2021-08-16 | $30.38M derived: sum of 3 quarters · filed 2022-03-31 | $36.98M derived: sum of 4 quarters · filed 2022-03-31 | ||||
| 2020-03-31 | $12.16M 10-Q · filed 2021-05-17 | $20.46M derived: sum of 2 quarters · filed 2022-03-31 | $27.06M derived: sum of 3 quarters · filed 2022-03-31 | $33.76M derived: sum of 4 quarters · filed 2022-03-31 | ||||
| 2019-12-31 | $8.30M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $14.90M derived: sum of 2 quarters · filed 2022-03-31 | $21.60M derived: sum of 3 quarters · filed 2022-03-31 | $27.37M 10-K · filed 2022-03-31 | ||||
| 2019-09-30 | $6.60M 10-Q · filed 2020-11-09 | $13.30M derived: sum of 2 quarters · filed 2020-11-09 | $19.07M 10-Q · filed 2020-11-09 | $24.53M derived: sum of 4 quarters · filed 2020-11-09 | ||||
| 2019-06-30 | $6.70M 10-Q · filed 2020-08-10 | $12.47M 10-Q · filed 2020-08-10 | $17.93M derived: sum of 3 quarters · filed 2020-08-10 | $23.22M derived: sum of 4 quarters · filed 2020-08-10 | ||||
| 2019-03-31 | $5.77M 10-Q · filed 2020-05-29 | $11.23M derived: sum of 2 quarters · filed 2020-05-29 | $16.52M derived: sum of 3 quarters · filed 2020-05-29 | $21.70M derived: sum of 4 quarters · filed 2020-05-29 | ||||
| 2018-12-31 | $5.46M derived: 10-K 12 month − 10-K 9 month · filed 2020-05-15 | $10.75M derived: sum of 2 quarters · filed 2020-05-15 | $15.93M derived: sum of 3 quarters · filed 2020-05-15 | $19.74M 10-K · filed 2020-05-15 | ||||
| 2018-09-30 | $5.29M 10-K · filed 2020-05-15 | $5.29M 10-Q · filed 2018-11-08 | $10.47M derived: sum of 2 quarters · filed 2020-05-15 | $14.29M 10-K · filed 2020-05-15 | $14.29M 10-Q · filed 2018-11-08 | $17.42M derived: sum of 4 quarters · filed 2020-05-15 | ||
| 2018-06-30 | $5.18M 10-K · filed 2020-05-15 | $5.18M 10-Q · filed 2018-08-09 | $8.99M 10-K · filed 2020-05-15 | $8.99M 10-Q · filed 2018-08-09 | $12.13M derived: sum of 3 quarters · filed 2020-05-15 | $15.09M derived: sum of 4 quarters · filed 2020-05-15 | ||
| 2018-03-31 | $3.81M 10-K · filed 2020-05-15 | $3.81M 10-Q · filed 2018-05-11 | $6.95M derived: sum of 2 quarters · filed 2020-05-15 | $9.91M derived: sum of 3 quarters · filed 2020-05-15 | $12.47M derived: sum of 4 quarters · filed 2020-05-15 | |||
| 2017-12-31 | $3.13M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15 | $6.10M derived: sum of 2 quarters · filed 2019-03-15 | $8.66M derived: sum of 3 quarters · filed 2019-03-15 | $11.02M 10-K · filed 2019-03-15 | ||||
| 2017-09-30 | $2.96M 10-Q · filed 2018-11-08 | $5.52M derived: sum of 2 quarters · filed 2018-11-08 | $7.89M 10-Q · filed 2018-11-08 | |||||
| 2017-06-30 | $2.56M 10-Q · filed 2018-08-09 | $4.92M 10-Q · filed 2018-08-09 | ||||||
| 2017-03-31 | $2.37M 10-Q · filed 2018-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B |